ASTRO Patient Summary: Long-Term Outcomes of RTOG 90-03: A Comparison of Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinoma

Carolyn Vachani, RN, MSN, AOCN
The Abramson Cancer Center of the University of Pennsylvania
Last Modified: October 27, 2005

Share article


Long-Term Outcomes of RTOG 90-03: A Comparison of Hyperfractionation and Two Variants of Accelerated Fractionation to Standard Fractionation Radiotherapy for Head and Neck Squamous Cell Carcinoma

Traditionally, radiation has been administered once a day for 5 days a week. In the late 1980's, some centers had been performing variations of twice-daily treatments to see if this could maximize cell killing. This study was opened to examine the various treatments being used. The study randomly assigned head and neck cancer patients to receive one of four regimens (see article for specific regimens). Initial data had been released in 2000, and this session presented data with an average 8.5 years of follow-up. The study found that "accelerated fractionation with concomitant boost" (AFC) and "hyperfractionation, twice daily", had better local control than the other regimens, meaning fewer recurrences at the site of the original tumor. Despite this advantage, these regimens were found to have more long-term side effects. Specifically, the AFC regimen had higher levels of toxicity occurring more than 4 years after treatment. These patients also had high rates of second cancers, with approximately 25% at 5 years and 40% at 10 years. The reviewer suggested continued long-term data from this study would be helpful, as would continued research into decreasing rates of long-term side effects.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More